DCM
PTX

DG Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

DG Capital Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-69,581
Closed -$2.2M – 16
2015
Q3 		$2.2M Buy
69,581
+954
+1% +$45.6K 2.56% 12
2015
Q2 		$4.06M Buy
+68,627
New +$4.84M 3.59% 11

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

DG Capital Management's PTX Position: Q4 2015 in Review

DG Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2015, closing a stake of 69,581 shares — an estimated $2.2M sold.

DG Capital Management first reported a position in PTX in Q2 2015 and held it in 2 quarters. The position peaked at $4.06M in Q2 2015. 101 funds tracked by Wall St. Rank hold PTX as of Q4 2015.

  • DG Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2015 after selling out during the quarter.
  • DG Capital Management sold 69,581 Pernix Therapeutics Holdings, Inc. shares in Q4 2015, an estimated $2.2M.
  • DG Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2015 and held it in 2 quarters.
  • DG Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $4.06M in Q2 2015.
  • 101 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2015.

Based on DG Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.